tiprankstipranks
Trending News
More News >
Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
:OACC
US Market
Advertisement

Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Stock News & Sentiment

Compare
0 Followers
Oaktree Acquisition Appoints Dr. Berry as Director
Premium
Company Announcements
Oaktree Acquisition Appoints Dr. Berry as Director
3d ago
The latest update is out from Oaktree Acquisition Corp. III Life Sciences Class A ( ($OACC) ). On October 17, 2025, Oaktree Acquisition Corp. III Life Sciences appointed Dr. David ...Read more
Oaktree Acquisition Corp. III Appoints New CFO
Premium
Company Announcements
Oaktree Acquisition Corp. III Appoints New CFO
5M ago

OACC News on the Web

News Score - Last 7 Days

Neutral
OACC
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OACC’s Media Buzz Sentiment?
1 articles about OACC were published this week. In an average week, 1 articles are published.
    What is OACC’s weekly average amount of articles?
    In an average week, 1 articles about OACC are published.
      What is OACC’s News Sentiment?
      59% of articles about OACC were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        IXIIXICO plc
        TDOCTeladoc
        ALNYAlnylam Pharma
        ANIPANI Pharmaceuticals
        VSTMVerastem
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis